Pacylex - Crunchbase Company Profile & Funding

Q: Where is Pacylex's headquarters?

Pacylex is located in Edmonton, Alberta, Canada.

Q: Who invested in Pacylex?

Pacylex has 3 investors including U.S. Department of Defense And Greenfire Bio.

Q: When was the last funding round for Pacylex?

Pacylex closed its last funding round on obfuscated from a Grant round.

Overview

Pacylex

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Pacylex

CB Rank

82017

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

Founded

obfuscation

Private

Grant

Edmonton, Alberta, Canada

1-10

www.pacylex.com/

Biotechnology

Health Care

Health Diagnostics

Funding Rounds

Grant

OBF

obfuscation

Series A

OBF

obfuscation

Convertible Note

OBF

obfuscation

Key People

Luc Berthiaume: Co-Founder and CSO
Ryan Heit: Co-Founder and COO

Details

Legal Name

Pacylex Pharmaceuticals, Inc.

Also Known As

Pacylex

Operating Status

Active

Company Type

For Profit

Founders

John Mackey, Luc Berthiaume, Ryan Heit

About the Company

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers. The company is developing a small molecule, oral chemotherapeutic, PCLX-001, to exploit this cancer mechanism by turning on selective lethality, apoptosis, in these cancer cells. The company's approach exploits a previously-unknown therapeutic target

in cancer, making the drug a first-in-kind therapy. The diagnostic technology identifies those patients who will benefit from the drug, sparing many patients needless treatment.

Pacylex Pharmaceuticals was founded on 2012 and is headquartered in Edmonton, Alberta, Canada.

Phone Number

1650-218-1840

Contact Email

info@pacylex.com

Predictions & Insights

Growth Insight

See this Growth Insight

Pacylex is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Zelenirstat

An oral small molecule inhibitor targeting N-myristoyltransferase (NMT) to disrupt myristoylation in cancer cells, used as a daily therapy for various cancers including hematologic malignancies and solid tumors.

NMT Inhibitors as ADC Payloads

Development of N-myristoyltransferase inhibitors as payloads for antibody-drug conjugates (ADCs) to target cancer cells selectively.

Research & Development

Pacylex is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant
obfuscated obfuscation	Grant - Pacylex	1	obfuscated obfuscation	U.S. Department of Defense	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Department of Defense	Yes	Grant - Pacylex	—
U.S. Department of Defense	Yes	Grant - Pacylex	—
U.S. Department of Defense	Yes	Grant - Pacylex	—
U.S. Department of Defense	Yes	Grant - Pacylex	—
U.S. Department of Defense	Yes	Grant - Pacylex	—